BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18245138)

  • 1. Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease.
    Alberici A; Bocchio L; Geroldi C; Zanardini R; Bonomini C; Bugari G; Iacobello C; Caimi L; Gennarelli M; Zanetti O; Valerio A; Nisoli E; Borroni B; Padovani A
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):712-5. PubMed ID: 18245138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration.
    Ishiki A; Kamada M; Kawamura Y; Terao C; Shimoda F; Tomita N; Arai H; Furukawa K
    J Neurochem; 2016 Jan; 136(2):258-61. PubMed ID: 26485083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral disturbances differentiate frontotemporal lobar degeneration subtypes and Alzheimer's disease: evidence from the Frontal Behavioral Inventory.
    Konstantinopoulou E; Aretouli E; Ioannidis P; Karacostas D; Kosmidis MH
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):939-46. PubMed ID: 23135894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD.
    Rosen HJ; Hartikainen KM; Jagust W; Kramer JH; Reed BR; Cummings JL; Boone K; Ellis W; Miller C; Miller BL
    Neurology; 2002 Jun; 58(11):1608-15. PubMed ID: 12058087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease.
    Heidler-Gary J; Gottesman R; Newhart M; Chang S; Ken L; Hillis AE
    Dement Geriatr Cogn Disord; 2007; 23(3):184-93. PubMed ID: 17220629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's Disease.
    Baldeiras I; Santana I; Leitão MJ; Ribeiro MH; Pascoal R; Duro D; Lemos R; Santiago B; Almeida MR; Oliveira CR
    J Neurol Sci; 2015 Nov; 358(1-2):308-16. PubMed ID: 26388316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease patients display gender dimorphism in circulating anorectic adipokines.
    Intebi AD; Garau L; Brusco I; Pagano M; Gaillard RC; Spinedi E
    Neuroimmunomodulation; 2002-2003; 10(6):351-8. PubMed ID: 12907842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of TMS to frontotemporal dementia variants.
    Alberici A; Bonato C; Calabria M; Agosti C; Zanetti O; Miniussi C; Padovani A; Rossini PM; Borroni B
    Acta Neurol Scand; 2008 Oct; 118(4):275-80. PubMed ID: 18397363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does executive impairment define a frontal variant of Alzheimer's disease?
    Woodward M; Brodaty H; Boundy K; Ames D; Blanch G; Balshaw R;
    Int Psychogeriatr; 2010 Dec; 22(8):1280-90. PubMed ID: 20719041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating leptin levels and weight loss in Alzheimer's disease patients.
    Power DA; Noel J; Collins R; O'Neill D
    Dement Geriatr Cogn Disord; 2001; 12(2):167-70. PubMed ID: 11173891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the driving behaviours of individuals with frontotemporal lobar degeneration and those with Alzheimer's disease.
    Fujito R; Kamimura N; Ikeda M; Koyama A; Shimodera S; Morinobu S; Inoue S
    Psychogeriatrics; 2016 Jan; 16(1):27-33. PubMed ID: 25735319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration.
    Barnes J; Whitwell JL; Frost C; Josephs KA; Rossor M; Fox NC
    Arch Neurol; 2006 Oct; 63(10):1434-9. PubMed ID: 17030660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and psychometric distinction of frontotemporal and Alzheimer dementias.
    Liscic RM; Storandt M; Cairns NJ; Morris JC
    Arch Neurol; 2007 Apr; 64(4):535-40. PubMed ID: 17420315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting clinical change with the CDR-FTLD: differences between FTLD and AD dementia.
    Mioshi E; Flanagan E; Knopman D
    Int J Geriatr Psychiatry; 2017 Sep; 32(9):977-982. PubMed ID: 27464599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of methodology for conducting clinical trials in frontotemporal lobar degeneration.
    Knopman DS; Kramer JH; Boeve BF; Caselli RJ; Graff-Radford NR; Mendez MF; Miller BL; Mercaldo N
    Brain; 2008 Nov; 131(Pt 11):2957-68. PubMed ID: 18829698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.
    Saraceno C; Catania M; Paterlini A; Fostinelli S; Ciani M; Zanardini R; Binetti G; Di Fede G; Caroppo P; Benussi L; Ghidoni R; Bolognin S
    J Alzheimers Dis; 2018; 61(4):1477-1483. PubMed ID: 29376863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study.
    Vignini A; Morganti S; Salvolini E; Sartini D; Luzzi S; Fiorini R; Provinciali L; Di Primio R; Mazzanti L; Emanuelli M
    Exp Gerontol; 2013 Dec; 48(12):1505-8. PubMed ID: 24400342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender effects on plasma PGRN levels in patients with Alzheimer's disease: a preliminary study.
    Piscopo P; Rivabene R; Galimberti D; Crestini A; Talarico G; Vanacore N; Scarpini E; Bruno G; Confaloni A
    J Alzheimers Dis; 2013; 35(2):313-8. PubMed ID: 23396349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.